Copyright
©The Author(s) 2025.
World J Diabetes. Nov 15, 2025; 16(11): 109919
Published online Nov 15, 2025. doi: 10.4239/wjd.v16.i11.109919
Published online Nov 15, 2025. doi: 10.4239/wjd.v16.i11.109919
Table 1 The results of the statistical comparison of general data between the two groups of patients, n (%)
| DN group (n = 115) | T2DM group (n = 115) | t/χ2 | P value | |
| Age (years old) | 70.32 ± 7.41 | 68.88 ± 8.29 | 1.468 | 0.144 |
| Sex | 1.430 | 0.232 | ||
| Male (cases) | 69 (60.00) | 60 (52.17) | ||
| Female (cases) | 46 (40.00) | 55 (47.83) | ||
| BMI (kg/m2) | 24.40 ± 2.15 | 24.21 ± 2.43 | 0.630 | 0.529 |
| Smoking (cases) | 43 (37.39) | 37 (32.17) | 0.690 | 0.406 |
| Drinking (cases) | 39 (33.91) | 47 (40.87) | 1.189 | 0.276 |
| Hypertension (cases) | 65 (56.52) | 73 (63.48) | 1.159 | 0.282 |
| Hyperlipidemia (cases) | 79 (68.70) | 84 (73.04) | 0.527 | 0.468 |
| Duration of diabetes (years) | 12.64 ± 3.91 | 9.57 ± 2.85 | 6.896 | 0.000 |
| eGFR (mL/min/1.73 m2) | 48.52 ± 9.77 | 78.92 ± 14.65 | -23.227 | 0.000 |
| Fasting blood glucose (mmol/L) | 7.59 ± 1.85 | 6.97 ± 1.88 | 2.507 | 0.013 |
| Fasting insulin level (mIU/L) | 9.53 ± 1.72 | 8.39 ± 1.19 | 5.847 | 0.000 |
| Blood uric acid (μmol/L) | 377.65 ± 65.23 | 358.07 ± 33.29 | 4.333 | 0.000 |
| Urea nitrogen (mmol/L) | 11.84 ± 2.03 | 8.67 ± 1.67 | 12.999 | 0.000 |
Table 2 Comparison of inflammatory indicators and trimethylamine N-oxide between the two groups of patients (mean ± SD)
| DN group (n = 115) | T2DM group (n = 115) | t | P value | |
| CRP (mg/L) | 12.16 ± 5.44 | 6.95 ± 1.77 | 5.760 | 0.000 |
| IL-6 (ng/L) | 331.14 ± 72.13 | 245.57 ± 42.04 | 9.749 | 0.000 |
| IL-8 (ng/L) | 345.04 ± 86.16 | 314.12 ± 75.13 | 10.659 | 0.000 |
| TNF-α (ng/L) | 11.28 ± 4.55 | 7.15 ± 1.80 | 2.972 | 0.003 |
| TMAO (ng/mL) | 123.47 ± 22.65 | 108.06 ± 17.62 | 9.041 | 0.000 |
Table 3 Comparison of bone metabolism indexes between the two groups (mean ± SD)
| DN group (n = 115) | T2DM group (n = 115) | t | P value | |
| PINP (μg/L) | 43.13 ± 6.11 | 35.51 ± 4.87 | 10.461 | 0.000 |
| β-CTX (ng/mL) | 0.51 ± 0.11 | 0.43 ± 0.08 | 5.996 | 0.000 |
| ALP (U/L) | 69.16 ± 7.12 | 65.61 ± 7.09 | 3.788 | 0.000 |
| Lumbar spine BMD (g/cm2) | 0.77 ± 0.14 | 0.81 ± 0.14 | -2.552 | 0.011 |
| Hip BMD (g/cm2) | 0.66 ± 0.11 | 0.71 ± 0.12 | -3.624 | 0.000 |
- Citation: Pan ZL, Li MQ, Zhang J, Xue LY, Shi YP. Correlation of gut microbiota metabolite trimethylamine N-oxide with inflammatory levels and osteoporosis in patients with diabetic nephropathy. World J Diabetes 2025; 16(11): 109919
- URL: https://www.wjgnet.com/1948-9358/full/v16/i11/109919.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i11.109919
